1,938 active funding opportunities
Supports neurologist- and neurosurgeon-scientists transitioning from NIH intramural roles to independent academic research and clinical positions.
Funds research education programs enhancing training in substance use and disorder research for clinicians and clinical researchers.
Funds advanced pre-clinical research on nanotechnology-based cancer diagnostics and therapeutics to improve treatment effectiveness.
Supports innovative multisite clinical trials leveraging NICHD Network infrastructure focused on women, children, pregnant and lactating women, and persons with disabilities.
Funds research on novel newborn screening methods and therapies for fatal or disabling conditions, including emerging genetic disorders.
Funds pilot projects to study understudied proteins linked to rare diseases, supporting preliminary data and tool development.
Supports research on novel newborn screening methods and therapies for fatal or disabling conditions, including high priority genetic disorders.
Funds pilot research on biological, behavioral, and social mechanisms contributing to HIV pathogenesis within NIDDK's mission, excluding clinical trials.
Funds innovative basic research on biological/genetic causes of cancer health disparities, including mechanistic studies and new methodologies.
Funds research on the harmful effects and delayed impacts of acute exposure to ultra-potent synthetic opioids like fentanyl and carfentanil.
Supports foundational research proposals in basic, applied, and advanced technology development for Army overmatch in future conflicts.
Funds innovative analysis of existing data to study drug use behaviors, prevention, and health service utilization, excluding clinical trials.
Supports innovative analysis of existing data to study drug use behaviors, prevention, and health service utilization.
Supports early translational research to identify and characterize therapeutic candidates for HLBS diseases, excluding clinical trials.
Funds early-stage translational research to develop medical device prototypes, identify disease targets, and create diagnostic assays for HLBS diseases.
Supports early translational research to identify and develop therapeutic candidates and combination products for HLBS diseases, excluding clinical trials.
Supports early-stage translational research for prototype testing and assay development targeting HLBS diseases, advancing products toward in vivo testing readiness.
Supports validation of transformative platforms to accelerate detection, diagnosis, and treatment of HLBS diseases, excluding clinical trials.
Supports Alaska Native entities in assessing and remediating contamination on ANCSA lands, including community outreach.
Supports CESU network partners with Master Cooperative Agreements for interdisciplinary research and resource stewardship projects across U.S. biogeographic regions.
Supports innovative applied research proposals that advance Army technologies and operational capabilities aligned with DEVCOM Analysis Center mission.
Supports phased cooperative agreements to plan and implement behavioral and social intervention clinical trials for dental, oral, or craniofacial conditions.
Funds phased cooperative agreement applications to plan and implement dental and craniofacial clinical trials under NIDCR mission.
Funds innovative nonmalignant hematology research projects focusing on basic and early translational studies without clinical trials.
